Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials.

Use of hydroxychloroquine to prevent congenital heart block in children of women with anti-SSA/Ro – SSB/La antibodies lacks evidence.

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned reproductive endocrinologist, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.

Citation Page #: 12(11);1039-45
Journal: Autoimmune Rev
Author Publication: Gleicher N, Elkayam U.
Publication Link: http://www.sciencedirect.com/science/article/pii/S1568997213000773
Date: 2013